Study: Benefits of Microdosing LSD Likely Placebo

Premium CBD Products


CBD 20% Discount

Researchers at the Imperial College London have found that the anecdotally reported benefits of microdosing LSD can likely be attributed to the placebo effect, The Guardian reports.

Their study — reportedly the largest-ever placebo-controlled investigation into the potential benefits of psychedelics — found that while daily small doses of LSD appeared to carry beneficial psychological effects, study participants in the placebo-controlled group reported equally positive results.

To conduct the study, researchers recruited 191 people who were already microdosing with LSD. Volunteers were told to prepare their LSD microdoses (approximately 13μg, each) and placebos ahead of time using gel capsules, then mix them up with envelopes. Each batch was flagged with a QR code which participants would scan before accessing, thus leaving participants unaware but allowing researchers to track whether a participant was actually taking LSD or just the placebo. The volunteers then completed surveys throughout the study’s four-week trial to log their experiences.

“Our findings confirmed some of the beneficial psychological effects of microdosing from anecdotal reports and observational studies, such as improved sense of wellbeing and life satisfaction. But we see the same improvements among participants taking placebos. This suggests that the improvements may not be due to the pharmacological action of the drug but can instead be explained by the placebo effect.” — Balázs Szigeti, lead author and research associate at Imperial College London’s Centre for Psychedelic Research

The medicinal use of psychedelics is growing in popularity with researchers around the world launching investigations. Last year, a study found that psilocybin — the mind-altering substance in psychedelic mushrooms — offered patients with depression “more than four times greater” relief than traditional antidepressant medications.

Additionally, the U.S. military allocated $17 million last June for medicinal psychedelic research.

Originally Published on 2021 03 04 by Graham Abbott | Ganjapreneur.com


Thank you for joining us today for our latest news post. If you have any questions or comments about this post, we’d love to hear from you in the comments! Join the FindHempCBD.com newsletter to stay up to date on the latest Industry News and keep an eye out for our next news article!


Disclaimer: This content was sourced from Ganjapreneur.com and republished to our website to add value and additional content for our readers. In order to maintain the safety, functionality, and integrity of FindHempCBD.com, the sourced content may have been altered. To access the original content, please click the link below:
https://www.ganjapreneur.com/study-the-benefits-of-microdosing-lsd-are-likely-placebo/

Pin It on Pinterest

Share This